GSK rises Thursday, still underperforms market
GSK PLC GSK shares inched up 0.03% to £14.97 Thursday, on what proved to be an all-around favorable trading session for the ...
Zacks.com on MSN16h
GSK's NDA for UTI Drug Gepotidacin Gets FDA's Priority Review
GSK plc GSK announced that the FDA has accepted its new drug application (NDA) seeking approval for its investigational, ...
devdiscourse1d
Global Health Updates: Innovations, Legal Battles, and Policy Shifts
Recent health news highlights various topics including Abbott's profit rise due to medical device sales, Trump's IVF comments ...
Decision to move library upheld despite doubts
A decision to relocate a town's library has been upheld despite a consultation into the plans being labelled unfair and not ...
EurekAlert!1d
BU, Boston Medical Center researchers join forces with GSK to fight lung diseases
Researchers from the Center for Regenerative Medicine at Boston University and Boston Medical Center have announced a new collaboration with the global biopharma company GSK to advance innovative ...
WPTV-TV1d
British drugmaker sues Moderna for patent infringement related to mRNA vaccines
A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...
radaronline1d
Brooke Shields Launches Shingles Campaign After Near-Death Health Scares: 'Women Aren't Taught to Put Their Health First'
Brooke Shields has teamed up on a health initiative for people over 50 after suffering a near-death experience last year.
Wave stock soars 73% on positive data for RNA editing treatment (update)
Wave Life Sciences (WVE) shares soared 66% after the company announced positive proof-of-mechanism data from a study of ...
BioPharma Dive1d
GSK claims Moderna infringed mRNA vaccine patents
The lawsuit focuses on scientific work that helped clear the path for creating mRNA vaccines to fight the COVID-19 pandemic.
GSK Seeks FDA Approval For Oral Antibiotic For Urinary Tract Infections, Probably First In New Class In Over 20 Years
GSK's gepotidacin, an oral antibiotic for uUTIs, could be the first in over 20 years. The FDA granted Priority Review with a ...
FierceBiotech1d
Wave hails first for human RNA editing with GSK-partnered prospect, sending stock skyward
Wave Life Sciences has taken a step toward validating a new modality, becoming the first group to report therapeutic RNA ...
BioSpace1d
As Sanofi Preps Consumer Healthcare Sale, Here’s a Look Back at Similar High-Profile Deals
When Sanofi announced last week that it plans to sell a 50% controlling stake of Opella, its consumer helath business, the ...